romosozumab
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Osteoporosis is characterized by induced bone mass and deterioration of the skeletal microstructural, which weakens bone strength…
Osteoporosis is a condition of compromised bone quality and bone density increasing the chances of fracture. In osteoporotic bone…
EULAR 2017: Romosozumab reduces the risk of clinical vertebral fractures in postmenopausal women with osteoporosis by as much as…
Treatment with sclerostin antibody (romosozumab) increases bone formation while reducing bone resorption, leading to increases in…
Blocking sclerostin (an osteocyte-derived negative regulator of bone formation) increases bone formation and reduces bone…
Sclerostin is an osteocyte-secreted glycoprotein that inhibits bone formation. By binding to sclerostin, the monoclonal antibody…
Results of a Phase II study suggest that romosozumab significantly increases bone mineral density (BMD) in the lumbar spine…